Vascular endothelial growth factor expression in pituitary adenomas
- PMID: 14753498
- DOI: 10.1007/978-3-7091-0651-8_106
Vascular endothelial growth factor expression in pituitary adenomas
Abstract
Vascular endothelial growth factor (VEGF) is known to be a mediator of angiogenesis and vascular permeability. A cystic component and hemorrhage are often found in pituitary adenomas. In the present study we assess the VEGF expression based on immunohistochemical examinations in 48 pituitary adenomas. All the adenomas showed some VEGF immunoreactivity mainly in the cytoplasm of tumor cells. Of the 48 adenoma-cases, 16 cases had a strong VEGF immunoreactivity, 26 cases had a moderate one, and 6 cases had a weak one. On the MR images, a cystic component was found in 16 cases (33.3%), and a hemorrhage was found in 18 cases (37.5%). The VEGF immunoreactivity had a significant relationship with the cystic component but neither the hemorrhage, size, recurrence, or HE classification. These findings suggest that VEGF might play a potential role in the pathogenesis of cystic formation in pituitary adenomas.
Similar articles
-
The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma.J Clin Neurosci. 2003 May;10(3):320-4. doi: 10.1016/s0967-5868(03)00013-4. J Clin Neurosci. 2003. PMID: 12763337
-
Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas.Tumori. 2011 Sep-Oct;97(5):639-46. doi: 10.1177/030089161109700517. Tumori. 2011. PMID: 22158497
-
Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.Acta Neurochir (Wien). 2000;142(12):1345-51. doi: 10.1007/s007010070003. Acta Neurochir (Wien). 2000. PMID: 11214627
-
Angiogenesis in pituitary adenomas.Microsc Res Tech. 2003 Feb 1;60(2):236-43. doi: 10.1002/jemt.10262. Microsc Res Tech. 2003. PMID: 12539178 Review.
-
Apoplexy of pituitary adenomas: the perfect storm.J Neurosurg. 2015 Jun;122(6):1444-9. doi: 10.3171/2014.10.JNS141720. Epub 2015 Apr 10. J Neurosurg. 2015. PMID: 25859802 Review.
Cited by
-
TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas.Int J Mol Sci. 2011;12(6):4165-79. doi: 10.3390/ijms12064165. Epub 2011 Jun 23. Int J Mol Sci. 2011. PMID: 21747731 Free PMC article.
-
Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.J Mol Histol. 2005 Oct;36(8-9):447-54. doi: 10.1007/s10735-005-9012-7. Epub 2006 May 19. J Mol Histol. 2005. PMID: 16733790
-
Targeting Aggressive Pituitary Adenomas at the Molecular Level-A Review.J Clin Med. 2021 Dec 27;11(1):124. doi: 10.3390/jcm11010124. J Clin Med. 2021. PMID: 35011868 Free PMC article. Review.
-
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review.Front Oncol. 2021 Nov 17;11:773905. doi: 10.3389/fonc.2021.773905. eCollection 2021. Front Oncol. 2021. PMID: 34869016 Free PMC article. Review.
-
Metabolomic and Transcriptomic Changes Underlying the Effects of L-Citrulline Supplementation on Ram Semen Quality.Animals (Basel). 2023 Jan 6;13(2):217. doi: 10.3390/ani13020217. Animals (Basel). 2023. PMID: 36670757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical